George Lundberg, MD Editor in Chief at Cancer Commons

  • January 31, 2022  

    NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for acute myeloid leukemia.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Small Cell Lung Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for small cell lung cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Cervical Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for cervical cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Kidney Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for kidney cancer.

    .

  • October 18, 2021  

    Novel Car-T Shows ‘Promising Early Signs of Clinical Efficacy’ for Diffuse Midline Gliomas Bookmark

    George Lundberg, MD

    Healio outlines results from a Stanford University study suggesting that a type of treatment known as CAR T-cell therapy is promising for children with diffuse midline gliomas. The treatment is still in an early phase of testing in humans.

    .

  • October 18, 2021  

    Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases Bookmark

    George Lundberg, MD

    This scientific editorial article from the Journal of Clinical Oncology discusses results from a clinical trial suggesting that addition of a treatment called transarterial radioembolization to standard treatment was not effective for people with colorectal cancer liver metastases that cannot be removed by surgery.

    .

  • October 18, 2021  

    Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience Bookmark

    George Lundberg, MD

    This scientific manuscript from Cureus reports results from a Toronto cancer center suggesting that stereotactic radiotherapy offers another option for palliative treatment of inoperable pancreatic cancer.

    .

  • October 18, 2021  

    Regularly Updated List of Recent FDA Approvals for Liver Cancer Bookmark

    George Lundberg, MD

    This resource from the U.S. Food and Drug Administration (FDA) lists recent drug approval announcements for liver cancer and related conditions. It also provides link to information about additional approvals that may not be announced.

    .

  • October 18, 2021  

    Running Virtual Trials with Self-Reported Brain Cancer Patient Data Bookmark

    George Lundberg, MD

    This scientific report from medRxiv demonstrates how self-reported data from brain cancer patients could be used to run “virtual trials” that complement traditional clinical trials by generating knowledge that could help inform precision cancer treatment.

    .

  • October 18, 2021  

    Results from Clinical Trial of Veliparib for People with Unmethylated Glioblastoma Bookmark

    George Lundberg, MD

    This scientific report from Neuro-Oncology outlines findings from a large, randomized clinical trial showing that the drug veliparib (a kind of drug known as a PARP inhibitor) added to radiotherapy and temozolomide did not improve progression-free survival in unmethylated glioblastoma.

    .